This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process (RA)
last updated: 16 Jun 2020
Summary risk assessment report on the application for Confined Field Trial of a novel Rift Valley Fever Vaccine in sheep, goats, cattle and camelsEN
25 Nov 2016
- Competent National Authority: | BCH-CNA-KE-8339-15National Biosafety Authority ()NACOSTI Building, Loresho, off Waiyaki WayNairobi, Nairobi
28251--00100, KenyaPhone: (+254) (20) (2678667),Fax:Email: firstname.lastname@example.org,Website: http://www.biosafetykenya.co.ke,